Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... Company

A world free of pain. This is our shared vision. To bring it to life, we execute our strategy and work on our company’s culture – everyday, everywhere, every one of us.

... We are Grünenthal

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

The Supervisory Board advises and controls the Corporate Executive Board and is elected by the shareholders’ summit.

... Supervisory Board

Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... Partnering

In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Grünenthal’s product portfolio, brands, ingredients and indication range.

... Products

Explore our media section and access a range of materials relating to our company, people, medicines and medical devices.

... Media

Grünenthal is a global leader in pain management and related diseases. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain. Explore our recent stories to see what drives us.

... Our Stories

In this section you will find both current and archived press releases published from 2013 onwards by Grünenthal GmbH, Germany.

... Press releases

... Statements

Journalists are invited to use our corporate publications for their reporting. The list contains business related publication like the company presentation or the code of conduct. .

... Corporate publications

Journalists are invited to use images from our library to illustrate their reporting. The library contains company and R&D related pictures.

... Image resources

The library contains a set of company footage. Journalists are invited to use the video material to illustrate their reporting.

... Video resources

Discover Grünenthal

7/20/2021

Flood disaster: Grünenthal donates 400,000 euros as emergency relief

Grünenthal provides 200,000 Euros in emergency aid for the City of Stolberg, which is significantly affected by the floods.
In addition, Grünenthal will donate 200,000 euros to the coalition "Germany Helps" (Aktion Deutschland Hilft).

Aachen, Germany, 20 July 2021 – Grünenthal is deeply saddened by the situation of the people affected by the flood disaster in Germany. Staff and executive management have set up a relief programme to provide immediate support for people who urgently need help.

Grünenthal donated 200,000 euros as immediate support for the severely affected town of Stolberg. The company will donate an additional 200,000 euros to the coalition "Germany Helps" (Aktion Deutschland Hilft) to support nationwide measures.

"Our thoughts and solidarity are with the people in our neighbourhood in the greater Aachen region and the other affected areas," says Gabriel Baertschi, CEO Grünenthal. "We will provide unbureaucratic support to the helpers on the ground."

Grünenthal supports employees who are personally affected by the flood disaster with financial and material means and paid leave.

About Grünenthal
Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain.

Grünenthal is headquartered in Aachen, Germany, and has affiliates in 29 countries across Europe, Latin America and the US. Our products are available in around 100 countries. In 2020, Grünenthal employed around 4,500 people and achieved sales of € 1.3 bn.

More information: www.grunenthal.com

Follow us on:

LinkedIn: Grunenthal Group
Instagram: grunenthal

Fabia Kehren, Head External Communications and Editorial Management

Fabia Kehren

Head of External Communication and Editorial Management

Grünenthal GmbH

52099 Aachen

E-Mail Fabia.Kehren@grunenthal.com

Phone +49 241 569-3269

... Back to overview